Pharmacokinetics and Safety of FFR-rFVIIa after Single Doses in Healthy Subjects
- 1 August 2001
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 41 (8) , 880-885
- https://doi.org/10.1177/00912700122010780
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pharmacokinetics of Recombinant Activated Factor VII (rFVIIa)Seminars in Thrombosis and Hemostasis, 2000
- Recombinant Factor VIIaBioDrugs, 1999
- Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis modelEuropean Journal of Vascular and Endovascular Surgery, 1998
- Antithrombotic Effects of Recombinant Human, Active Site–Blocked Factor VIIa in a Rabbit Model of Recurrent Arterial ThrombosisCirculation Research, 1998
- Platelet activity of high‐dose factor VIIa is independent of tissue factorBritish Journal of Haematology, 1997
- Incorporation of an Active Site Inhibitor in Factor VIIa Alters the Affinity for Tissue FactorPublished by Elsevier ,1997
- Prevention of experimental arterial thrombosis by topical administration of active site–inactivated factor VIIaJournal of Vascular Surgery, 1997
- Influence of Blockade at Specific Levels of the Coagulation Cascade on Restenosis in a Rabbit Atherosclerotic Femoral Artery Injury ModelCirculation, 1995
- Initiation and regulation of tissue factor-dependent blood coagulation.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.Proceedings of the National Academy of Sciences, 1989